Literature DB >> 12809805

Evidence for the presence of a type III secretion system in diffusely adhering Escherichia coli (DAEC).

C M Kyaw1, C R De Araujo, M R Lima, E G S Gondim, M M Brígido, L G Giugliano.   

Abstract

Diffusely adhering Escherichia coli (E. coli) strains (DAEC) represent a potential cause of diarrhoea in infants, and the detection of type three secretion system (TTSS) genes in DAEC would substantiate their pathogenic nature. In this work, four isolates of DAEC, recovered from stools of diarrhoeic children, were analysed by PCR, in order to detect the presence of TTSS genes. Primers targeted to the escC, escJ, escN and escV, some of the most conserved TTSS genes in enteropathogenic and enterohaemorrhagic Escherichia coli (EPEC and EHEC), were used in order to verify the occurrence of homologous genes in our DAEC isolates. By this approach, we were able to characterise DNA fragments corresponding to putative escJ and escN genes in all DAEC isolates. Furthermore, DNA fragments homologous to the escC and escV genes were also amplified from all isolates. Besides the similarity found among the DAEC esc homologues with EPEC and EHEC esc genes, the nucleotide sequence analysis of the flanking regions of the amplified DNA fragments suggests that the putative DAEC esc genes are organised in the same manner as observed in EPEC and in EHEC strains. The results described here provide strong evidence for the presence of a TTSS in the DAEC strains analysed, implicating a pathogenic nature of these isolates.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12809805     DOI: 10.1016/s1567-1348(03)00008-x

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  8 in total

1.  Comparative analysis of locus of enterocyte effacement pathogenicity islands of atypical enteropathogenic Escherichia coli.

Authors:  Julia F Gärtner; M Alexander Schmidt
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

2.  Comparative Genomics of Atypical Enteropathogenic Escherichia coli from Kittens and Children Identifies Bacterial Factors Associated with Virulence in Kittens.

Authors:  Victoria E Watson; Tracy H Hazen; David A Rasko; Megan E Jacob; Johanna R Elfenbein; Stephen H Stauffer; Jody L Gookin
Journal:  Infect Immun       Date:  2021-02-16       Impact factor: 3.441

3.  Diarrhea-associated biofilm formed by enteroaggregative Escherichia coli and aggregative Citrobacter freundii: a consortium mediated by putative F pili.

Authors:  Alex L Pereira; Thiago N Silva; Ana Cmm Gomes; Ana Cg Araújo; Loreny G Giugliano
Journal:  BMC Microbiol       Date:  2010-02-23       Impact factor: 3.605

4.  Virulence gene profiles and molecular genetic characteristics of diarrheagenic Escherichia coli from a hospital in western China.

Authors:  Dan Li; Min Shen; Ying Xu; Chao Liu; Wen Wang; Jinyan Wu; Xianmei Luo; Xu Jia; Yongxin Ma
Journal:  Gut Pathog       Date:  2018-08-17       Impact factor: 4.181

5.  Influence of the intestinal microbiota on disease susceptibility in kittens with experimentally-induced carriage of atypical enteropathogenic Escherichia coli.

Authors:  Victoria E Watson; Megan E Jacob; José M Bruno-Bárcena; Sophia Amirsultan; Stephen H Stauffer; Victoria O Píqueras; Rafael Frias; Jody L Gookin
Journal:  Vet Microbiol       Date:  2019-03-18       Impact factor: 3.293

6.  Diffusely adherent Escherichia coli strains isolated from children and adults constitute two different populations.

Authors:  Rosane Mansan-Almeida; Alex Leite Pereira; Loreny Gimenes Giugliano
Journal:  BMC Microbiol       Date:  2013-02-01       Impact factor: 3.605

7.  Survival and replication of Escherichia coli O157:H7 inside the mice peritoneal macrophages.

Authors:  Ayman Al-Mariri
Journal:  Braz J Microbiol       Date:  2008-03-01       Impact factor: 2.476

8.  Diversity of Virulence Genes in Multidrug Resistant Escherichia coli from a Hospital in Western China.

Authors:  Xue Li; Qi Luo; Xinyu Yu; Yanling Zhang; Xiaoyue Cao; Dan Li
Journal:  Infect Drug Resist       Date:  2019-12-05       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.